Clay Siegall is the founder of the Seattle-based firm called Seattle Genetics. He studied in Maryland University where he undertook a B.S. in zoology and held a Ph.D. in genetics from the University of George Washington. Seattle Genetics specializes in therapy for diseases that have not shown any improvement in the past decades.
Seattle Genetics aims at improving scientific inventions by carrying out intensive research on drugs to help patients suffering from cancer. Dr. Siegall is a scientist by profession whose focus is on cancer therapies. He has led Seattle Genetics since 1998 with his leadership building an antibody-drug conjugate (ADC) to treat cancer.
Recently, more people get diagnosed with cancer hence using radiation and chemotherapy methods to treat the disease. However, human genetics is changing thus there is a dire need to improve the treatment of the disease. Dr. Clay B. Siegall has devoted to helping companies research an effective medicine for cancer. Earlier cancer testing is vital because it identifies the effective treatment of the disease.
DNA tests through genome sequencing identify errors in cancerous cells and healthy cells. In such a case, we use genomic medicine to gear protection to the genetic code of the patient. Genomic medicine shows an exceptional promise towards cancer treatment.
Genome sequencing is essential in the cancer therapy since it detects the active treatment. Also, it saves doctors time of trying different medication with a risk that a patient may get the wrong medication. In fact, it keeps the doctors’ performance with a possible clue to cancer treatment.
In other news, researchers from the University of England have come up with a way to identify bladder cancer. Using the urine test, a doctor can detect crude protein, TERT, in the urine. Recent analysis shows that the test is 80 percent accurate as compared to cytology testing which was rated 34 percent accurate.
Summing up, Netherlands has come up with an exciting and more promising way to diagnose prostate cancer. Unlike in the past years where the diagnoses would take months to get an accurate treatment, this method will save lives if detected in early stages.